About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, April 1st, 2015

The QualityStocks
Daily Stock List

graphic
graphic

ProGreen Properties, Inc. (PGEI)

Penny Stock Rumble, SmallCapStockPlays, StockMister, Real Pennies, FeedBlitz, and StockHotTips reported on ProGreen Properties, Inc. (PGEI), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

ProGreen Properties, Inc. works to transform residential real estate into income-producing investment opportunities. It acquires and develops real estate properties then converts them into high yield investments. The ability for smaller initial investments allows the Company to offer a chance for all investors to own shares and join in the real estate market. ProGreen Properties has its corporate headquarters in Birmingham, Michigan.

Regarding its business model, ProGreen Properties purchases properties and turns them into attractive, energy-efficient, as well as healthier homes. The Company either sells them on the open market, or leases to suitable tenants who are willing to pay a little more so they can live in a ProGreen property, and then subsequently sell the unit to property investors.

ProGreen’s wholly-owned subsidiaries are ProGreen Realty LLC, purchasing, leasing and sale of properties; ProGreen Property Management LLC, management of properties sold to investors; and ProGreen Construction LLC, an in house construction company.

ProGreen offers for sale to European investors, fully managed income producing residential real estate that produce returns that far exceed what is the standard in Europe, and still keep healthy margins as well as maintaining the property.

ProGreen Properties entered into an agreement with American Residential Gap ApS (Denmark) in April of 2012, to acquire fully managed and leased investment properties from ProGreen. The first sale was closed on April 30, 2012. They have continued to purchase properties from ProGreen.

ProGreen Properties announced in a press release on December 17, 2014 that it was entering into a joint venture (JV) with American Residential Gap LLC (ARG), a real estate investment company in Sweden. This resulted in the creation of PAJV LLC (PAJV) in late December. The JV is based on ARG providing 100 percent of all funding in real estate projects performed by PAJV. ProGreen will handle everything from acquisition to sale. Realized profits from the individual projects are then split 50/50 between the two parties. This cooperative JV is gaining momentum in the U.S. market.

ProGreen Properties, Inc. (PGEI), closed Wednesday's trading session at $0.04, up 66.67%, on 546,165 volume with 50 trades. The average volume for the last 60 days is 12,614 and the stock's 52-week low/high is $0.015/$0.034.

Generex Biotechnology Corp. (GNBT)

OTCPicks, PennyTrader Publisher, and Greenbackers reported previously on Generex Biotechnology Corp. (GNBT), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Generex Biotechnology Corp. engages in the research, development, and commercialization of drug delivery systems and technologies. It has developed a proprietary platform technology for the delivery of drugs into the human body via the oral cavity, with no deposit in the lungs. Its proprietary liquid formulations enable drugs normally administered through injection to undergo absorption into the body through the lining of the inner mouth using its proprietary RapidMist™ device. Its buccal insulin spray product is Generex Oral-lyn™.

Antigen Express, Inc. is a wholly-owned subsidiary of Generex Biotechnology. The Antigen Express subsidiary is a platform technology and product-based entity. The core platform technologies of Antigen Express consist of immunotherapeutic vaccines for the treatment of malignant, infectious, allergic, and autoimmune diseases. Antigen Express is developing proprietary vaccine formulations for active immunotherapy and disease prevention. 

Generex’s RapidMist™ is an advanced buccal drug delivery technology. It consists of a proprietary formulation and a proprietary device design, which can deliver drugs through the buccal mucosa safely. RapidMist™ has been shown to have a rapid onset of action with no lung deposition, precise dosage control, easy use and handling, and improved patient compliance.

The Company’s Generex Oral-lyn™ is an insulin spray for the treatment of Type I and Type II diabetes. Generex Oral-lyn™ is a safe, simple, quick, effective, and pain-free alternative to subcutaneous injections of prandial insulin. It is conveniently delivered to the membranes of the oral cavity through a straightforward asthma-like device with no pulmonary (lung) deposition. 

The Antigen Express subsidiary has pioneered the use of specific CD4+ T-helper stimulation technologies in immunotherapy. One technology focuses on the modification of peptides with Ii-Key to increase potency. A second technology relies on inhibition of expression of the Ii protein. Antigen Express scientists, and others, have shown clearly that suppression of expression of the Ii protein in cancer cells allows for strong stimulation of T-helper cells and prevents the further growth of cancer cells. Antigen Express is developing the AE37 breast cancer vaccine.

In March, Generex Biotechnology provided an update on the status of the buccal insulin formulation enhancement project for its proprietary Generex Oral-lyn™ buccal insulin spray product. The project has moved ahead under the supervision of Dr. David Brusegard, Ph.D., the Company's Chief Operating Officer (COO), Dr. James H. Anderson, Jr., MD, the Company's Senior Scientific Advisor, and Generex consultant Dr. Lakshmi P. Kotra, B. Pharm.(Hons), Ph.D.

Dr. Brusegard stated:  "We are pleased to report that our preliminary efforts have succeeded in increasing the insulin concentration in the product by approximately 400 percent via in vitro testing while preserving the solubility and stability of insulin in the formulation."

Generex Biotechnology Corp. (GNBT), closed Wednesday's trading session at $0.019, even for the day, on 1,325,450 volume with 32 trades. The average volume for the last 60 days is 1,189,869 and the stock's 52-week low/high is $0.0105/$0.0435.

Boston Therapeutics, Inc. (BTHE)

Stock News Now and RedChip reported recently on Boston Therapeutics, Inc. (BTHE), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Boston Therapeutics, Inc. is a developer of complex carbohydrate therapeutics to treat diabetes and inflammatory diseases. The Company’s product pipeline focuses on developing and commercializing therapeutic molecules that address diabetes and inflammatory diseases. Additionally, the Company developed and markets SUGARDOWN®. This is a non-systemic complex carbohydrate-based dietary food supplement. The design of SUGARDOWN® is to support healthy blood glucose. Boston Therapeutics has its headquarters in Manchester, New Hampshire.

The Company’s product pipeline includes BTI-320. This is a non-systemic chewable complex carbohydrate-based compound. The design of it is to reduce post-meal glucose elevation. BTI-320 is a proprietary polysaccharide. It is to be taken before meals.

BTI-320 works in the gastrointestinal tract to block the action of carbohydrate-hydrolyzing enzymes, which break down complex carbohydrates into simple sugars, decreasing the availability of glucose for absorption into the bloodstream. The Company has entered into a clinical trial agreement with Joslin Diabetes Center to be the lead clinic in a Phase II study of BTI-320. The trial is scheduled to begin in Q2 2015.  

The Company’s product pipeline also includes IPOXYN. This is an injectable anti-necrosis drug. The design of it initially is to treat lower limb ischemia associated with diabetes.

In November 2014, Boston Therapeutics and Advance Pharmaceutical Company Ltd., via its subsidiary SugarDown Company Ltd. of Hong Kong, agreed to expand its’ marketing agreement for Boston Therapeutics' SUGARDOWN® to include 13 additional nations in Asia. The territory expansion comes because of the continued regulatory filings and marketing clearance authorizations that are being granted as Advance Pharmaceutical continues its market registration expansion.

With this original agreement, SugarDown Company can market SUGARDOWN® in China, Hong Kong, and Macau. The new agreement expands the marketing initiative to Korea, Taiwan, Japan, Singapore, Thailand, Malaysia, Vietnam, Philippines, Myanmar, Indonesia, Laos, Brunei and Cambodia. Advance Pharmaceutical has already been granted marketing approval in Singapore, Macau, and Korea along with Hong Kong. The main China registration will enter the clinical testing phase this year, with a projected approval tentatively set for later in 2015.   

Last week, Boston Therapeutics announced that its affiliate Advanced Pharmaceutical initiated the SUGARDOWN® clinical trial in Hong Kong. Advance Pharmaceutical will evaluate the effect of SUGARDOWN® on Post-Prandial Hyperglycemia in Chinese subjects with Pre-Diabetes. Dr. Andria Luk and Dr. Juliana CN Chan, PRCP are the lead principal investigators. The lead clinical site is the Department of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital.

Boston Therapeutics, Inc. (BTHE), closed Wednesday's trading session at $0.20, down 6.10%, on 50,583 volume with 12 trades. The average volume for the last 60 days is 19,772 and the stock's 52-week low/high is $0.14/$0.80.

Innovus Pharmaceuticals, Inc. (INNV)

StockMister, Penny Stock Circle, StockMarketQuote.us, 1-2-3 Stock Alerts, Fortune Stock Alerts, and OTPicks reported earlier on Innovus Pharmaceuticals, Inc. (INNV), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Innovus Pharmaceuticals, Inc. is an emerging pharmaceuticals company. It delivers non-prescription over-the counter (OTC) medicine and consumer care products to improve men and women's health and vitality. The Company markets its products in the United States and Canada through retailers and on the web. Moreover, Innovus details its products to urologists, gynecologists and sex therapists. It does so either directly in the United States or through commercial partners worldwide.  Innovus Pharmaceuticals is based in San Diego, California.

The Company’s current product portfolio consists of Zestra® (for female arousal, desire and satisfaction), EjectDelay™ (for premature ejaculation), Sensum+™ (for reduced penile sensitivity - for sales outside the U.S. only), Zestra Glide® (a high viscosity low molarity female water based lubricant) and Vesele®. Vesele® is a proprietary, novel, and safer oral dietary supplement to maximize nitric oxide's beneficial effects on sexual function and brain health. Vesele® contains a patented formulation of L-Arginine and L-Citrulline, in combination with the natural absorption enhancer Bioperine®.

Innovus Pharmaceuticals entered into an exclusive marketing and distribution agreement with Tramorgan Limited, a British company. Innovus has granted to Tramorgan an exclusive marketing sales and distribution right to market and sell Innovus’ topical consumer care product to increase penile sensitivity, Sensum+™, in the United Kingdom. The agreement has an initial term of December 31, 2016.
 
Today, Innovus Pharmaceuticals announced that its 2014 revenues increased in its first full year of commercial operations. The Company signed roughly $2 million in minimum annual orders from its seven commercial partners for its products. Its revenues increased to more than $1,000,000 in 2014. This is up from $6,641 in 2013. At December 31, 2014, Innovus had more than $1,000,000 million in cash available under its Line of Credit (LOC) with its CEO and President, Dr. Bassam Damaj, and $191,600 in accounts receivable and no going concern opinion from its auditors.

Innovus Pharmaceuticals has in-licensed the product, Androferti® (in the U.S. and Canada) to support overall male reproductive health and sperm quality. In addition, it has added a number of large online retailers for its products. These include Swanson Health, Pharmapac, and Quest. Furthermore, it acquired FlutiCare™ (Fluticasone Propionate Nasal Spray for Allergic Rhinitis). It expects to launch this in 2016, subject to the U.S. Food and Drug Administration's approval of the abbreviated new drug application for the OTC version.

Innovus Pharmaceuticals, Inc. (INNV), closed Wednesday's trading session at $0.1415, up 1.07%, on 108,250 volume with 22 trades. The average volume for the last 60 days is 39,692 and the stock's 52-week low/high is $0.1105/$0.50.

Bank of the Carolinas Corp. (BCAR)

Dynamic Wealth Report reported previously on Bank of the Carolinas Corp. (BCAR), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Founded in 1998, Bank of the Carolinas Corp. is the holding company for Bank of the Carolinas, which is a North Carolina chartered bank based in Mocksville, North Carolina. Bank of the Carolinas provides commercial and consumer banking services chiefly in the Piedmont region of North Carolina. The Bank also has offices in Advance, Asheboro, Concord, Harrisburg, Landis, Lexington, and Winston-Salem. It provides its products and services mainly to individuals, and small-and medium-sized businesses. Bank of the Carolinas’ shares trade on the OTC Markets Group’s OTCQB.

The Bank began its operations in December of 1998 as a state chartered bank. It currently has the above-mentioned eight offices in the Piedmont region. Bank of the Carolinas competes for loans and deposits throughout the markets it serves. It garners the majority of its revenue from net interest income. This is the difference between the income it earns from loans and securities and the interest expense it incurs on deposits and borrowings.

Bank of the Carolinas provides business and individual checking accounts, savings accounts, negotiable order of withdrawal accounts, certificates of deposit, and money market checking accounts. It also provides fixed interest rate certificates with varying maturities.

In addition, the Bank provides consumer and commercial loans for various personal, business, and agricultural purposes, including term and installment loans, commercial and equity lines of credit, and overdraft checking credit. Furthermore, it provides commercial operating and working capital loans, residential mortgage loans, home equity lines of credit, other consumer loans, and loans secured by commercial real estate.

In 2014, the Board of Directors of Bank of the Carolinas Corp. and its wholly owned subsidiary, Bank of the Carolinas (the Bank), appointed Mr. Harvey L. Glick as a Director and elected him as Chairman. Mr. Glick was most recently President and Chief Executive Officer of Insight Bank, Worthington, Ohio, from 2008 until 2014.

Bank of the Carolinas Corp. (BCAR), closed Wednesday's trading session at $0.135, even for the day, on 113,964 volume with 8 trades. The average volume for the last 60 days is 42,228 and the stock's 52-week low/high is $0.121/$1.35.

Delta Oil & Gas, Inc. (DLTA)

Club Penny Stocks Network reported today on Delta Oil & Gas, Inc. (DLTA), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Delta Oil & Gas, Inc. is an oil and gas exploration and production company based in Vancouver, British Columbia. It engages in the acquisition, development, and production of oil and natural gas properties in North America. The Company works to acquire and develop properties with undeveloped reserves that are economically attractive. Delta Oil & Gas lists on the OTCQB.

Presently, Delta’s focus is on the exploration of its land portfolio consisting of working interests (WIs) in Newton County, Texas and South Central Oklahoma. It looks to create value and reduce risks through acquiring and developing property interests in areas that have significant undeveloped reserves; are in close proximity to developed markets for oil and natural gas; have existing infrastructure or the ability to install the Company’s own infrastructure of oil and natural gas; and pipelines and production platforms.

Delta Oil & Gas reported in April of 2014 that natural gas and condensate production for its earlier drilled and completed Donner #4 well, located in Newton County, Texas, showed signs of stabilized production at roughly 400 MCF per day of sweet gas and 1- 2 barrels of condensate per day. For the Company, the expectation is that this completed well will be a solid producer at a consistent rate into the future.

The Donner #4 well is the third successful well drilled in the prospect for Delta Oil & Gas and its partner, Hillcrest Resources Ltd. The previously drilled Donner #1 has been consistently flowing high quality oil at a daily rate of between 40 and 48 barrels of oil. The Donner #1 production has not changed in close to two years. It shows no signs of decline or water intrusion. The previously drilled Donner #2 sweet gas well is producing in the range of 400 MCF of natural gas per day.

On August 20, 2012, Delta acquired its 10 percent WI in the Garcia #3 and the continuing development rights in the field with an agreement with Progas Energy Services LLC, to jointly develop the field located in Jim Wells County, Texas (the Premont Northwest Field). The first four wells in the field have shown oil stains in at least one zone per well. Delta’s first well, Laughlin Kibby #1, began production during the first quarter ended March 31, 2014.

Delta Oil & Gas maintains a low cost structure by way of relationships with established oil and gas companies and operators. It continues to concentrate on increasing net asset value through participating in an active drilling program in partnership with its strategic relationships.

Delta Oil & Gas, Inc. (DLTA), closed Wednesday's trading session at $0.014, down 44.00%, on 10,461 volume with 5 trades. The average volume for the last 60 days is 20,035 and the stock's 52-week low/high is $0.01/$0.145.

Centrue Financial Corp. (CFCB)

We are highlighting Centrue Financial Corp. (CFCB) today, here at the QualityStocks Daily Newsletter.

Centrue Financial Corp. is the parent company of Centrue Bank. Centrue Financial is a regional financial services company and it serves a market area that extends from the far western and southern suburbs of the Chicago metropolitan area across Central Illinois down to the metropolitan St. Louis area. Centrue Financial lists on the OTC Markets Group’s OTCQB. Founded in 1982, Centrue Financial has its headquarters in Ottawa, Illinois.

Centrue Financial has 24 locations and it has total assets of approximately $890 million, total loans of $580 million, and total deposits of $770 million. Its Centrue Bank provides commercial and retail banking services to individual and corporate customers. The Bank accepts diverse deposit products. These include checking accounts, business savings accounts, money market accounts, business certificates of deposit, as well as demand and time deposits.

Centrue Bank’s loan portfolio consists of commercial real estate loans and construction loans; commercial loans; 1-4 family residential real estate and home equity loans, and consumer loans. In addition, it consists of lines of credit, equipment and machinery financing; farm real estate loans; and government lending programs. The Bank also offers mortgage banking, brokerage, asset management, and trust services, as well as debit and credit cards.

This past February, Centrue Financial announced its 2014 results. The Company reported a full year net loss of $4.5 million, or ($1.49) per common diluted share, versus net income of $3.7 million, or $0.24 per common diluted share, for the same period in 2013. In Q4 2014, it reported a net loss of $6.0 million, or ($1.54) per common diluted share, versus a net loss of $0.3 million or ($0.14) per common diluted share for Q4 2013.

Q4 and full year 2014 results were impacted by a loss of $3.9 million attributable to a bulk asset sale. The 2013 results were impacted by a $4.7 million gain on sale of pooled trust preferred securities. Excluding these items, Centrue Financial’s core results improved $400,000 from year-end 2013 to year-end 2014. Centrue Bank remains well-capitalized at the end of Q4 2014 with total risk-based capital of 11.84 percent and tier 1 leverage capital of 7.61 percent.

Centrue Financial Corp. (CFCB), closed Wednesday's trading session at $0.44, up 15.79%, on 166,800 volume with 35 trades. The average volume for the last 60 days is 4,846 and the stock's 52-week low/high is $0.36/$1.04.

graphic

The QualityStocks
Company Corner

graphic
graphic

Inventergy Global, Inc. (INVT)

The QualityStocks Daily Newsletter would like to spotlight Inventergy Global, Inc. (INVT). Today, Inventergy Global, Inc. closed trading at $0.45, on 2,073,807 volume with 2,164 trades. The stock’s average daily volume over the past 60 days is 296,704, and its 52-week low/high is $0.3904/$10.52.

Inventergy Global, Inc. today announced that it has entered into definitive agreements with several institutional investors and accredited investors to purchase a total of $2.15 million of common stock of the Company, consisting of 4,673,914 shares of common stock at $0.46. Gross proceeds will be approximately $2.15 million, which the Company intends to use for working capital purposes in support of its intellectual property (IP) licensing strategies. The closing of the offering is expected to take place on or before April 7, 2015, and is subject to the satisfaction of customary closing conditions.

Inventergy Global, Inc. (INVT) is an intellectual property (IP) licensing partner specializing in IP value creation. Led by industry veteran Joe Beyers, former head of global licensing for Hewlett-Packard, Inventergy identifies, acquires and licenses patented technologies to help market-leading technology companies monetize and achieve more value from their innovations.

With more than 100 years of combined experience and track record of handling more than $15 billion in IP and technology transactions, Inventergy’s team of professionals handle every aspect of the IP business, from valuation and branding through legal analysis, decision making and patent sales.

Inventergy partners with world-class, market-significant companies who may lack internal manpower, budget or other resources necessary to realize appropriate return-on-investment. Through collaborative, business-centered, and forward-thinking strategies, Inventergy is able to create portfolios with significant market potential and optimize the innovator’s overall return-on-investment.

The company has established a network of key industry relationships to complement its solid licensing model and growing portfolio of assets, which currently stands at more than 760 global patent assets. Inventergy pursues maturing telecommunications technologies already adopted in the marketplace and earning accretive value. Disclaimer

Inventergy Global, Inc. Company Blog

Inventergy Global, Inc. News:

Inventergy Announces $2.15 Million Common Stock Financing to Accelerate Licensing Operations

Inventergy Announces CEO & Chairman Joe Beyers to Present at IPBC Global 2015, San Francisco

Inventergy Announces Operational Restructuring of Its Product Businesses Designed to Improve Margins, Cash Flow and Earnings Growth

Zenosense, Inc. (ZENO)

The QualityStocks Daily Newsletter would like to spotlight Zenosense, Inc. (ZENO). Today, Zenosense, Inc. closed trading at $0.2125, up 6.25%, on 2,700 volume with 4 trades. The stock’s average daily volume over the past 60 days is 25,974, and its 52-week low/high is $0.13/$1.00.

Zenosense, Inc. (ZENO) is developing and intends to market a novel device to enable hospitals to detect Methicillin-resistant Staphylococcus Aureus (MRSA) bacterial contamination, a major constituent of Hospital Acquired Infections (HAIs). The annual costs of treating hospitalized MRSA patients are estimated to be between $3.2 billion and $4.2 billion in the United States alone. MRSA infected patients are likely to spend three times as long in a hospital stay at three times the cost, and are five times more likely to die than an uninfected patient.

Early detection of MRSA and HAIs in general is vital. Recent studies suggest that implementing prevention practices can lead to up to a 70 percent reduction in certain HAIs with a financial benefit of using these prevention practices estimated to be as high as $25.0 billion to $31.5 billion in medical cost savings in the United States alone (according to a report by the Centers for Disease Control and Prevention, part of the US Department of Health and Human Sciences). Currently, no cost effective early detection device is available.

The Zenosense MRSA detection device is expected to act like a “smoke detector” for MRSA; designed to detect MRSA in the environment or infected patient, even before a patient demonstrates any obvious symptoms, satisfying this huge unmet need.

Zenosense has an agreement with leading European sensor developer Sgenia Group, which is developing such a device exclusively for Zenosense through their subsidiary Zenon Biosystem. The estimated manufacturing cost per device is under $100 USD and possibly as low as $50 USD. The Zenosense device, utilizing established Sgenia programming and patent-pending hardware, utilizes a single sensor to perform an infinite number of scans, creating tens of thousands of "virtual sensors". The low cost and compact design of the Zenosense device, if successfully developed, would make it possible to be worn by individuals, as well as placed in numerous sensitive areas in the healthcare setting.

Zenosense has a streamlined management team experienced in high-level marketing in the medical sector, supported by the outsourced Zenon Biosystem scientific/development team of qualified personnel with extensive knowledge and experience in the development of sensors. Both of these teams will fuse together through a high level advisory board of experienced professionals. A cost-effective Zenosense MRSA detection device, once developed, is expected to be in high demand, driven by patient safety, cost and insurance considerations. Disclaimer

Zenosense, Inc. Company Blog

Zenosense, Inc. News:

Zenosense, Inc. - Hospital Collaboration - 400 Person Lung Cancer Detection Trial

Zenosense, Inc.; Stock Now DTC DWAC/FAST Eligible

Zenosense, Inc. Reports Manufacturing of Pre-Commercial Lung Cancer Detection Device

Mobile Lads Corp. (MOBO)

The QualityStocks Daily Newsletter would like to spotlight Mobile Lads Corp. (MOBO). Today, Mobile Lads Corp. closed trading at $0.10605, up 0.05%, on 11,300 volume with 2 trades. The stock’s average daily volume over the past 60 days is 39,320, and its 52-week low/high is $0.091/$0.42.

Mobile Lads Corp. (MOBO) designs and delivers secure, wide-area wireless transaction software solutions for the consumer finance, web and health payment processing sectors. The company’s solutions provide streamlined, continuous access to time-sensitive information and data on multiple network standards. Mobile Lads’ products and services, offered through its Xtreme Mobility division, centers on three core technologies that simplify and secure wireless communications: xmVerify, xmBilling, and xmOne.

xmVerify is a real-time mobile transaction security service that prevents credit card fraud by giving users control over the authorization process when making purchases. Using one of the best cryptographic services, and in compliance with most all available platforms, xmVerify sends a transaction authorization request directly to the user’s mobile phone to ensure authenticity.

xmBilling is a mobile platform that provides customers with a convenient and secure way to review and authorize automatic billing transactions, easing the challenges of automated and volume-based billing. The system sends the user a text message with a URL leading to an online e-bill where they can review details of the bill and authorize the payment via credit card with the use of their PIN number.

The xmOne mobile platform provides an array of encrypted mobile services, including top-up, payment processing, emergency notification and marketing, ideal for students and higher education facilities. xmOne interfaces with a school’s existing campus card account system to enable students to perform a variety of banking transactions from their cell phones. The university or college benefits from increased usage of the flex-dollar ecosystem, reduces overhead from ADMs, and can be customized to each school’s individual brand.

Mobile Lads is guided by a management team with a unique blend of in-depth technical expertise in wireless channel communications and a solid background in business strategy and consumer analysis. The company’s vision is to grow as a leading-edge wireless solution provider by enabling innovative, wide-area communication solutions on a global scale. Disclaimer

Mobile Lads Corp. Company Blog

Mobile Lads Corp. News:

Mobile Lads Begins Operating And Buys Control Of North American Shopping Network Simbadeals.com From DoMark International

Mobile Lads Begins Operating North American Shopping Network Simbadeals.com

Mobile Lads Purchases Majority of North American Shopping Network From Domark International

Well Power Inc. (WPWR)

The QualityStocks Daily Newsletter would like to spotlight Well Power Inc. (WPWR). Today, Well Power Inc. closed trading at $0.0085, off by 5.56%, on 1,218,031 volume with 18 trades. The stock’s average daily volume over the past 60 days is 269,345, and its 52-week low/high is $0.0072/$0.3299.

Well Power Inc. (WPWR) has secured the licensing rights to Texas with the first right of refusal on the other US states to a new technology solution to process waste natural gas, such as vented, flared or stranded gas, into “clean power” and engineered fuels, including no-sulphur diesel and diluents. Based on proprietary technology, this solution is mobile, high-yield and can be deployed with minimum capital expenditure.

The company plans to be able to provide its technology with full-service engineering, design, construction, modular fabrication, maintenance and construction management services to clients in the upstream areas of exploration and production. Well Power will also offer consulting services, process assessments, facility appraisals, feasibility studies, technology evaluations, project finance structuring and support, and multi-client subscription services.

Approximately 2.4 million barrels of oil equivalent is wasted each day by gas flaring alone, resulting in $10 billion of lost revenue and 400 million metric tons of CO2 equivalent global greenhouse gas emissions each year. Additionally, environmental degradation associated with gas flaring has been shown to have a significant impact on local populations, often resulting in loss of livelihood and severe health issues.

Well Power’s Micro Refinery Unit (MRU) offers the opportunity to create value from a wasted resource while simultaneously enabling wider access to energy, improved environmental conditions, and economic development for local populations. By eliminating legacy flaring and minimizing new flaring, the company is well positioned to take a leadership role in the ongoing push for sustainable resource development and energy efficiency. Disclaimer

Well Power Inc. Company Blog

Well Power Inc. News:

Well Power Inc. Appoints Professional Engineer, Oil & Gas Veteran to Board of Directors

Well Power - Letter from President to Shareholders

Well Power Inc. to host second webinar on proprietory micro-refinery technology

One World Holdings, Inc. (OWOO)

The QualityStocks Daily Newsletter would like to spotlight One World Holdings, Inc. (OWOO). Today, One World Holdings, Inc. closed trading at $0.0064, off by 15.79%, on 10,587,137 volume with 132 trades. The stock’s average daily volume over the past 60 days is 4,602,767, and its 52-week low/high is $0.0008/$0.1786.

One World Holdings, Inc. (OWOO) subsidiary, The One World Doll Project, was established in 2010 to make a significant positive cultural impact through the doll category, transcending global and ethnic borders to create positive self-image in young women and girl around the world. Led by worldwide famous doll designer Stacy McBride-Irby, The One World Doll Project team has more than 50 collective years in the doll and toy industry and is dedicated and armed with the experience to ensure that the dolls are of the highest quality and value.

In 2013, the company released its Prettie Girls!™ line of multi-cultural fashion dolls uniquely designed with individual physical attributes, personal stories and hobbies, and goals and inspirations. For young girls, the dolls are a friend, a partner in play, and a glimpse of their biggest, brightest dreams. For young women, the dolls are a symbol of who they are and what they can achieve. For doll connoisseurs, The One World Doll Project promises stylish works of art that will become a vital part of a growing collectors’ market.

The One World Doll Project also has a Signature Celebrity Collection of Prettie Girls! and in 2013 released its first celebrity collectors doll modeled after supermodel Cynthia Bailey from The Real Housewives of Atlanta. Since the release of the doll, it has been showcased with Synthia on The Arsenio Hall Show, What Happens Live with Andy Cohen and The Bethenny Show.

Using a web-based sales model, One World Holdings plans to quickly capture significant market share in the dolls and stuffed toys space. After securing a strong online presence, the company will focus on brick and mortar retailing as it moves toward the ultimate pursuit of expanding worldwide. The company has established distribution deals with Toys “R” Us, HEB, dollgenie.com, Tuckers Toy Shop, pattycakedoll.com, and has recently expanded its retail presence internationally with the People’s Pharmacy storechain in the Central American country of Belize. The Prettie Girls! Dolls have been featured in national and international media spotlights like CNN, The Wall Street Journal, Jet Magazine, Bloomberg.com, Parade.com, Dolls Magazine, The Toy Book, The Houston Chronicle and Houston Business Journal, and TheStreet.com. Disclaimer

One World Holdings, Inc. Company Blog

One World Holdings, Inc. News:

One World Holdings Raises Capital to Fund National Expansion and Convertible Note Elimination

The One World Doll Project to Announce National Retail Store Roll Out of the Prettie Girls! Dolls On April 6 Conference Call

The One World Doll Project CEO Announces 2015 Revenue Projections in Stockholder Letter

Consorteum Holdings, Inc. (CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.0022, even for the day. The stock’s average daily volume over the past 60 days is 71,239, and its 52-week low/high is $0.0013/$0.018.

Consorteum Holdings, Inc. (CSRH) has spent the last 3 years developing relationships and licensing agreements to take the center stage in the emerging market of mobile gaming. The company has the capability to deliver rich mobile content to end users who will use their smart phones in ways that could not even have been imagined five years ago.

Specializing in delivery of mobile content, mobile payment solutions and products through a mix of on-deck partnerships, license agreements, and joint venture revenue share arrangements, the company operates as a technology and services aggregator to meet the diverse needs of its client base. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.

ThreeFiftyNine Inc., a wholly owned subsidiary, hired a software development team that had previously designed the world’s first regulatory compliant mobile platform for delivery of gaming content created by a third party. The platform, which has met the rigorous standards of the Nevada Gaming Board, the gold standard in regulatory gaming, represents the first generation software delivery platform for mobile devices. The development team spent the past 5 years and millions of dollars in non-recurring engineering costs to complete the development of the platform. At the heart is the capability to deliver any digital content across any cellular network to any mobile device. This key differentiator makes it possible for Consorteum to approach many different markets that are in the business of providing mobile connectivity and mobile content.

Consorteum’s mobile initiatives will benefit multiple business verticals. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer

Consorteum Holdings, Inc. Company Blog

Consorteum Holdings, Inc. News:

Consorteum Holdings Signs License Agreement With NYG Holdings

Consorteum Holdings Signs Mobile Application Development Contract With Bet Butler Limited

Consorteum Holdings Launches New Mobile Results App for Popular Keno Game

Car Monkeys Group (CKMY)

The QualityStocks Daily Newsletter would like to spotlight Car Monkeys Group (CKMY). Today, Car Monkeys Group closed trading at $0.22, even for the day. The stock’s average daily volume over the past 60 days is 1,308, and its 52-week low/high is $0.10/$5.00.

Car Monkeys Group (CKMY), via CarMonkeys.com, is one of the largest and fastest growing online cars, vans and SUV parts distributors in the United States. Founded in 2010, the Wyckoff, New Jersey-based company formerly was known as Delaine Corporation and changed its name to Car Monkeys Group in February 2015.

With access to hundreds of thousands of parts, Car Monkeys sells used, high-quality, low-mileage automotive parts to consumers, retailers, truck and car fleet owners and auto repair facilities looking for a wide range of vehicle makes and models. Customers have access to a Part Finder section that helps them easily navigate and quickly locate the right parts they need.

Striving to provide customers a quick, hassle-free and convenient shopping experience, all parts ordered through CarMonkeys.com ship from one of the company’s numerous distributors and auto dismantling centers straight to the customer or their mechanic. Advantages such as a five-year unlimited mileage warranty, zero shipping costs, and a generous return policy further contribute to the increasing popularity of the Car Monkeys brand.

Automotive recycling plays a substantial role in the preservation of natural resources and reduction of demand for landfill space. According to the Automotive Recyclers Association, approximately 95% of vehicles retired from use are processed for recycling, saving an estimated 85 million barrels of oil that would have been used to manufacture new or replacement parts. As a rapidly growing and trusted automotive recycling company, Car Monkeys is positioned as a leading player in the broader $22 billion North American automotive recycling industry. Disclaimer

Car Monkeys Group Company Blog

Car Monkeys Group News:

Car Monkeys Group (CKMY) Announces Engagement of QualityStocks Investor Relations Services

Car Monkeys Group (CKMY) is “One to Watch”

Car Monkeys Group (CKMY) Continues Growth as one of the Country’s Largest Online Automobile Parts Distributors

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

PennyStockLocks.com
(THCZ)

2.

Zacks
(IMDZ)

3.

QualityStocks
(RIHT)

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251